Charles Harrington

Dr Harrington has extensive research experience in the field of neurodegenerative diseases and is author of more than 50 publications and co-inventor in 12 patent applications in this area. He has collaborated with Professor Wischik for over 30 years, developing assays for screening agents having the potential to prevent the tau pathology that is the hallmark of Alzheimer’s disease.